allogeneic human umbilical cord-derived mesenchymal stem cells (Trustem)

N/A

Report date: 2025/01/26 18:22:20

Base Information

Drug Nameallogeneic human umbilical cord-derived mesenchymal stem cells (Trustem)
Drug Alias Namemesenchymal stem cell therapy (Trustem)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesColombia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrustem
China Registration ClassN/A

Develop Information

Active CompaniesTrustem
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A